Propranolol, infantile haemangiomas, and serendipity: new use for an old drug
Capillary haemangiomas are benign lesions that may occur anywhere on the skin, may grow rapidly in the first two years of life and may impair vital organs. Propranolol has been recently discovered to shrink these lesions effectively. We report the first such patient treated in Malta with this drug.
Main Authors: | Carmen Scerri, Victor Grech |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2011-01-01
|
Series: | Libyan Journal of Medicine |
Subjects: | |
Online Access: | http://www.libyanjournalofmedicine.net/index.php/ljm/article/view/5826/pdf_85 |
Similar Items
-
Haemangioma of Infancy: Two Case Reports with an Overdose of Propranolol
by: S.R. Janmohamed, et al.
Published: (2011-02-01) -
Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study
by: Sasha Wilson, et al.
Published: (2022-09-01) -
Comparing the effectiveness of propranolol versus atenolol in inducing clinical clearance in the treatment of infantile haemangioma: A randomised controlled trial
by: Raihan Ashraf, et al.
Published: (2023-01-01) -
Update on Infantile Haemangioma
by: Zohreh Hajheydari, et al.
Published: (2014-02-01) -
Update on Infantile Haemangioma
by: Zohreh Hajheydari, et al.
Published: (2014-02-01)